GO ASIA Success Story: LoopLab Bio

In this interview, we feature LoopLab Bio, an Austrian biotech startup developing innovative immunology therapies that aim to re-educate the immune system rather than suppress it. Their technology has the potential to treat allergies, autoimmune diseases, and prevent anti-drug antibody formation, addressing some of the most pressing challenges in modern healthcare.

The video highlights LoopLab Bio’s participation in the GO JAPAN program, which provided access to key life science conferences and industry events across Japan. During the journey, the team connected with leading stakeholders from universities, pharmaceutical companies, biotech firms, and venture capital organizations. Key highlights included attending BioJapan, the EU-Japan Pharma & Biotech Conference, the Austrian Business Summit, and Expo, all of which helped strengthen their international network and explore strategic opportunities for growth.

Discover how LoopLab Bio is advancing next-generation immunology treatments and leveraging international collaborations to accelerate innovation in the life sciences sector: looplab.bio

GO ASIA supports Austrian startups in their expansion towards Asia. More about the program:gin-austria.com/programs/goAsia

ilmed by  @NikiTexler ​